2017
DOI: 10.1016/j.hjdsi.2017.06.007
|View full text |Cite
|
Sign up to set email alerts
|

Antibiotic stewardship in the retail clinic setting: Implementation in 1100 clinics nationwide

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
6

Relationship

1
5

Authors

Journals

citations
Cited by 7 publications
(5 citation statements)
references
References 7 publications
0
5
0
Order By: Relevance
“…However, the average age of patients in these studies was 40 years. One national chain of retail clinics has reported on the implementation of a centralized multifaceted stewardship program across more than 1100 sites with associated low rates of inappropriate antibiotic prescribing . However, critics have pointed out that the ease of accessibility of retail clinics may promote healthcare use and subsequent antibiotic prescriptions for patients who have low‐acuity conditions and require only supportive care …”
Section: Ambulatory Care Stewardship Interventionsmentioning
confidence: 99%
“…However, the average age of patients in these studies was 40 years. One national chain of retail clinics has reported on the implementation of a centralized multifaceted stewardship program across more than 1100 sites with associated low rates of inappropriate antibiotic prescribing . However, critics have pointed out that the ease of accessibility of retail clinics may promote healthcare use and subsequent antibiotic prescriptions for patients who have low‐acuity conditions and require only supportive care …”
Section: Ambulatory Care Stewardship Interventionsmentioning
confidence: 99%
“…The major stakeholders of ASPs include infectious disease (ID) physicians [21], clinical pharmacists [22,23], infection control practitioners [24], and nurses [25] who are playing their defined and expanded roles in preventing and treating infectious diseases. Numerous countries have implemented ASPs in different healthcare settings to get optimal health benefits in terms of reduction in AMR as well as cost-effectiveness in drug therapy [26,27,28,29,30].…”
Section: Introductionmentioning
confidence: 99%
“…Our findings showed E. coli (22,42%) as the prevalent Gram-negative bacteria, 45,45% ESBLs and AmpC 37,71% producers in the same group, which resembles the previous mentioned study and others from countries with similar socio-demographic conditions in which predominated E. coli (22,2% Sudan, 28% Cuba) 4,24,25 and ESBLs production of 49,2% 4 ; whereas a research conducted in Spain to assessed multi-resistant gram-negative bacteremia exposed production rates of 80% ESBLs and 8% AmpC 8 . Made an impression the low rate of isolation of carbapenemase-producing gramnegative bacilli and that there is no previous report of it in our region 26 .…”
Section: Discussionmentioning
confidence: 78%
“…Empirical use of beta-lactams with extended spectrum or cephalosporins of 1 to 3 generation is not recommended due to the high resistance found. Alternatively, if resistance to an antibiotic group already exists, we would suggest to start a cyclic replacement, which is performed with antibiotics of different mode of action until the resistance to the former relapses 5,7,10,26,30,31 .…”
Section: Discussionmentioning
confidence: 99%